UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Federated Hermes
FHI
$4.78B
| $1.98M | ﹤0.01% |
59,125
+4,000
| +7% | +$138K |
|
1352
NETGEAR
NTGR
$659M
| $1.97M | ﹤0.01% |
65,672
+5,900
| +10% | +$185K |
|
1353
Spectrum Brands
SPB
$2.09B
| $1.97M | ﹤0.01% |
19,306
-17,510
| -48% | -$1.65M |
|
|
THS
1354
DELISTED
Treehouse Foods
THS
| $1.97M | ﹤0.01% |
24,299
+2,800
| +13% | +$216K |
|
|
INVN
1355
DELISTED
Invensense Inc
INVN
| $1.97M | ﹤0.01% |
130,226
-490,475
| -79% | -$7.41M |
|
|
INN
1356
Summit Hotel Properties
INN
$739M
| $1.95M | ﹤0.01% |
149,917
+12,570
| +9% | +$167K |
|
1357
Timken Company
TKR
$9.1B
| $1.95M | ﹤0.01% |
53,330
-9,500
| -15% | -$379K |
|
1358
Winnebago Industries
WGO
$904M
| $1.95M | ﹤0.01% |
82,548
+2,850
| +4% | +$60.7K |
|
1359
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $1.93M | ﹤0.01% |
40,187
| – | – |
|
1360
Rollins
ROL
$18.1B
| $1.93M | ﹤0.01% |
152,174
+11,025
| +8% | +$124K |
|
1361
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.95B
| $1.93M | ﹤0.01% |
44,386
+1,449
| +3% | +$66.3K |
|
1362
West Pharmaceutical
WST
$24.7B
| $1.92M | ﹤0.01% |
33,083
+2,485
| +8% | +$139K |
|
1363
FirstCash
FCFS
$9.02B
| $1.92M | ﹤0.01% |
42,035
-316
| -0.7% | -$15K |
|
|
EXL
1364
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $1.92M | ﹤0.01% |
121,479
+45,041
| +59% | +$707K |
|
1365
Kirby Corp
KEX
$7.01B
| $1.91M | ﹤0.01% |
24,897
-9,400
| -27% | -$745K |
|
1366
Terex
TEX
$7.55B
| $1.91M | ﹤0.01% |
82,058
+6,500
| +9% | +$171K |
|
|
TCF
1367
DELISTED
TCF Financial Corporation
TCF
| $1.9M | ﹤0.01% |
114,657
+7,800
| +7% | +$125K |
|
|
CVA
1368
DELISTED
Covanta Holding Corporation
CVA
| $1.9M | ﹤0.01% |
89,783
+12,247
| +16% | +$267K |
|
1369
ScottsMiracle-Gro
SMG
$3.85B
| $1.9M | ﹤0.01% |
32,011
+2,700
| +9% | +$171K |
|
1370
Wendy's
WEN
$1.52B
| $1.89M | ﹤0.01% |
167,482
+15,700
| +10% | +$173K |
|
|
PNY
1371
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $1.89M | ﹤0.01% |
53,498
+5,200
| +11% | +$192K |
|
1372
Armstrong World Industries
AWI
$7.86B
| $1.89M | ﹤0.01% |
35,429
+2,500
| +8% | +$139K |
|
|
AIRM
1373
DELISTED
Air Methods Corp
AIRM
| $1.88M | ﹤0.01% |
45,454
-43,864
| -49% | -$1.92M |
|
1374
Designer Brands
DBI
$339M
| $1.87M | ﹤0.01% |
56,123
+8,200
| +17% | +$293K |
|
|
PSB
1375
DELISTED
PS Business Parks, Inc.
PSB
| $1.87M | ﹤0.01% |
25,950
+700
| +3% | +$53.4K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.